Which Advance Market Commitment (AMC) will get funded first?
➕
Plus
5
Ṁ455
2026
39%
Broad-spectrum antivirals
38%
Diagnostics for neonatal sepsis
22%
Repurposing generic drugs

The University of Chicago Market Shaping Accelerator (MSA) awarded three top prizes for market shaping proposals as part of their Innovation Challenge:

https://marketshaping.uchicago.edu/news/announcing-winners-of-the-inaugural-msa-innovation-challenge/

Which will receive significant funding to bring their solution to life?

Conditions:


- Does not strictly have to be an AMC, it could be some other form of committed funding
- It has to be funded with $100,000,000 USD (or more)
- Will resolve according to an announcement (blog post, press release, tweet) by the University of Chicago Market Shaping Accelerator

- Will extend the deadline as necessary

Get Ṁ1,000 play money
Sort by:

I practice as a healthcare regulatory attorney and I can tell you that "repurposing generic drugs" will definitely require legislation

There's no way that legislation will get passed before this market resolves